CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

200 hedge funds and large institutions have $2.73B invested in Cymabay Therapeutics in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 33 closing their positions.

Holders
200
Holders Change
+11
Holders Change %
+5.82%
% of All Funds
2.93%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
46
Increased
79
Reduced
60
Closed
33
Calls
$84.7M
Puts
$20.6M
Net Calls
+$64.2M
Net Calls Change
+$62M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$105M
2
BlackRock
2
BlackRock
New York
$227M
3
VPC
3
Vestal Point Capital
New York
$38.4M
4
FTM
4
First Turn Management
California
$35.4M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$72.3M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$42.5M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$62.1M
3
NIP
3
Nicholas Investment Partners
California
$10.3M
4
FCMI
4
Foresite Capital Management IV
California
$0
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$144M
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$262M 11,111,111 +811,111 +8%
BlackRock
2
BlackRock
New York
$227M 9,610,239 +1,818,243 +23%
RCM
3
RA Capital Management
Massachusetts
$164M 6,940,000 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$149M 6,306,149 +558,562 +10%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$144M 6,103,797 -699,687 -10%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$105M 4,465,161 +2,561,460 +135%
PA
7
Perceptive Advisors
New York
$95.1M 4,024,400 -18,791 -0.5%
Jennison Associates
8
Jennison Associates
New York
$94.3M 3,992,711 +437,437 +12%
Franklin Resources
9
Franklin Resources
California
$77.2M 3,267,927 -39,988 -1%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$72.3M 3,061,996 +1,493,048 +95%
Holocene Advisors
11
Holocene Advisors
New York
$70.7M 2,993,945 -123,740 -4%
State Street
12
State Street
Massachusetts
$66.1M 2,797,916 +511,972 +22%
OCA
13
Octagon Capital Advisors
New York
$63.2M 2,673,750 -400,000 -13%
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$62.1M 2,628,000 -1,497,000 -36%
Point72 Asset Management
15
Point72 Asset Management
Connecticut
$60.8M 2,573,700 +143,776 +6%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$56.2M 2,380,105 +304,549 +15%
FAM
17
Fred Alger Management
New York
$46.5M 1,967,858 -204,451 -9%
Morgan Stanley
18
Morgan Stanley
New York
$45.2M 1,913,890 +1,406,419 +277%
CAM
19
Cormorant Asset Management
Massachusetts
$42.5M 1,800,000 -2,050,000 -53%
VPC
20
Vestal Point Capital
New York
$38.4M 1,625,000 +1,625,000 New
FTM
21
First Turn Management
California
$35.4M 1,497,331 +1,497,331 New
SI
22
Sofinnova Investments
California
$33.3M 1,411,769 +1,411,769 New
Deutsche Bank
23
Deutsche Bank
Germany
$32.5M 1,377,964 +921,858 +202%
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
$31.2M 1,321,219 +1,321,219 New
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$27.4M 1,161,964 – –
1
2 3 4 5